Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons
Transplant Infectious Disease, 05/03/2012McKinnell JA et al.
Patients who have undergone organ or stem cell transplant remain at risk for PCP for many years after transplantation. In the cohort, patients who developed NH–PCP were rarely given prophylaxis, and initiation of appropriate antibiotics was significantly delayed compared to cases of HIV–PCP. Medical providers should be aware of the ongoing risk for NH–PCP, even late after transplantation, and consider more aggressive approaches to both prophylaxis and earlier empirical therapy for PCP.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.